Close Menu
Home › Bio-Rad Q2 Revenues Fall 2 Percent

Bio-Rad Q2 Revenues Fall 2 Percent

Aug 03, 2017

This story has been updated from a previous version to include comments made during Bio-Rad's earnings call.

NEW YORK (GenomeWeb) – Bio-Rad reported after the close of the market on Thursday that its second quarter revenues fell 2 percent on both a reported and currency-neutral basis.

For the three months ended June 30, Bio-Rad reported $504.7 million in net sales compared to $516.8 million in the year-ago quarter and short of analysts' average estimate of $515.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

May
08
Featured Webinar

OncoBEAM ctDNA Testing for Early Response Prediction and Therapy Surveillance in Melanoma and Pancreatic Cancer

Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

What's Popular?

In PCR

  1. Bruker TB Test, PCR Platform Receives CE-IVD Mark

  2. Blood-Based PTSD Diagnostic Being Developed by Indiana University Team

    Premium

  3. GenePOC Strep A Test Granted FDA Clearance

  4. SpeeDx Signs Distributor Deals in Middle East

  5. Oxford Biodynamics Joins UK Prostate Cancer Screening Trial

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.